Modified transketolase and use thereof
AssigneeDsm IP Assets B.V.
InventorsMichael Hans, Dietmar Laudert, Hans-Peter Hohmann, Martin Lehmann
Life of this patent
Estimating the term…
Abstract
The present invention relates to a improved process for the biotechnological production of compounds for which ribose-5-phosphate, ribulose-5-phosphate or xylulose-5-phosphate is biosynthetic precursor like riboflavin (vitamin B2), FAD, FMN, pyridoxal phosphate (vitamin B6), guanosine, GMP, adenosine, AMP. The invention further pertains to the generation of the organism producing those compounds. It furthermore relates to the generation of mutated transketolases that allow normal growth on glucose but reduced growth on gluconate when introduced into the production strains and to polynucleotides encoding them.
Claims6
A modified transketolase originated from Bacillus or Corynebacterium, wherein the amino acid sequence of the modified transketolase contains at least one mutation, so that the specific activity of the modified enzyme is reduced in comparison to the corresponding non-modified wild-type enzyme, said at least one mutation leading to a reduced activity of between 10 to 90% towards metabolism of carbon sources that are exclusively metabolized by the pentose phosphate pathway compared to the activity of the respective non-modified wild-type enzyme.
A modified transketolase used in a process for producing riboflavin, wherein at least one mutation is introduced such that, in the process for producing riboflavin, after replacing the wild-type transketolase(s) of a riboflavin-producing host cell with the modified one, the growth rate of the generated new strain on a carbon source that is metabolized exclusively by the pentose phosphate pathway is reduced in comparison to the growth rate of the original host cell containing the wild-type transketolase to a growth rate of between 10 to 90% in comparison to the host cell containing the wild-type transketolase.
Dependencies are inferred from the claim text.